Back to News
Market Impact: 0.32

Barclays initiates Commercial Metals stock with Equalweight rating

Analyst InsightsCompany FundamentalsCorporate EarningsM&A & RestructuringManagement & Governance
Barclays initiates Commercial Metals stock with Equalweight rating

Barclays initiated Commercial Metals Company at Equalweight with a $75 price target, versus a $70.70 share price, saying the stock is fairly valued given its construction-cycle exposure and above-peer leverage. The company also reported Q2 2026 revenue of $2.13 billion, beating estimates by $40 million, while EPS of $1.16 missed the $1.30 consensus by 10.8%. UBS separately upgraded CMC to Buy with an $89 target, citing lower U.S. rebar pricing risk, while recent acquisitions and a board appointment add to the company’s strategic backdrop.

Analysis

CMC looks like a late-cycle construction beneficiary that has already harvested most of the “good news” from M&A and mix improvement. The market is now paying for a levered exposure to non-residential construction just as the incremental upside from pricing and volume may be getting less elastic, which explains why upgrades are arriving even as the stock stops being cheap on a relative basis. In other words, the stock can stay supported without being a great risk-adjusted buy here unless end-demand accelerates again. The second-order issue is balance sheet optionality: higher leverage matters less in a stable tape, but it becomes a real equity-valuation drag if rates stay elevated or if rebar and construction activity soften over the next 2-4 quarters. Because the recent acquisitions expand margin but also raise integration and execution risk, any earnings miss tied to M&A costs could cause a sharper de-rating than the headline revenue beat would suggest. That makes the next few print-to-print periods more important than the full-year narrative. The contrasting read is that the market may be underappreciating how much of CMC’s rerating already occurred in the last 12 months. If UBS is right that rebar risk has eased, the cleaner expression is not chasing CMC outright but owning the beneficiary basket with less balance-sheet sensitivity. For UBS, the positive implication is more about sentiment spillover across levered industrial cyclicals than about CMC itself; for peers, the bar to outperform from here may be lower if they have stronger free cash flow and less acquisition drag.